Entity Public Float of KalVista Pharmaceuticals, Inc. from 30 Jun 2015 to 31 Oct 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
KalVista Pharmaceuticals, Inc. quarterly Entity Public Float in USD history and change rate from 30 Jun 2015 to 31 Oct 2024.
  • KalVista Pharmaceuticals, Inc. Entity Public Float for the quarter ending 31 Oct 2024 was $440,082,646, a 61% increase year-over-year.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $440,082,646 +$166,922,646 +61% 31 Oct 2024 10-K 10 Jul 2025 2025 FY
Q3 2023 $273,160,000 +$153,539,941 +128% 31 Oct 2023 10-K 11 Jul 2024 2024 FY
Q3 2022 $119,620,059 -$259,027,593 -68% 31 Oct 2022 10-K 10 Jul 2023 2023 FY
Q3 2021 $378,647,652 +$96,443,011 +34% 31 Oct 2021 10-K 07 Jul 2022 2022 FY
Q3 2020 $282,204,641 +$117,926,466 +72% 31 Oct 2020 10-K 13 Jul 2021 2021 FY
Q3 2019 $164,278,175 -$13,651,018 -7.7% 31 Oct 2019 10-K 01 Jul 2020 2020 FY
Q3 2018 $177,929,193 +$117,641,224 +195% 31 Oct 2018 10-K 16 Jul 2019 2019 FY
Q3 2017 $60,287,969 +$48,680,522 +419% 31 Oct 2017 10-K 30 Jul 2018 2018 FY
Q3 2016 $11,607,447 31 Oct 2016 10-K 27 Jul 2017 2017 FY
Q2 2015 $88,485,047 30 Jun 2015 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.